44.40
price up icon0.87%   0.385
pre-market  Vorhandelsmarkt:  44.62   0.225   +0.51%
loading

Exelixis Inc Aktie (EXEL) Neueste Nachrichten

pulisher
05:18 AM

Will Exelixis Inc. (EX9) stock outperform energy sector in 20252025 Trading Recap & Low Risk High Win Rate Picks - Newser

05:18 AM
pulisher
04:28 AM

Will Exelixis Inc. stock attract more institutional investorsTrend Reversal & Reliable Entry Point Trade Alerts - Newser

04:28 AM
pulisher
Dec 04, 2025

Will Exelixis Inc. (EX9) stock beat Nasdaq index returns2025 Stock Rankings & Growth Oriented Trading Recommendations - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

How forex fluctuations impact Exelixis Inc. (EX9) stockRisk Management & Weekly Stock Performance Updates - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Will Exelixis Inc. (EX9) stock profit from automation wave2025 Analyst Calls & Technical Confirmation Trade Alerts - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Why Exelixis Inc. (EX9) stock appeals to dividend investorsTreasury Yields & AI Forecasted Stock Moves - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Why Is Exelixis (EXEL) Up 9% Since Last Earnings Report? - Yahoo Finance

Dec 04, 2025
pulisher
Dec 04, 2025

Will Exelixis Inc. (EX9) stock rise with strong economyWeekly Stock Summary & Smart Money Movement Alerts - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

How Exelixis Inc. (EX9) stock compares with top peers2025 Market Overview & Safe Entry Momentum Stock Tips - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Can Exelixis Inc. (EX9) stock beat analyst consensusWeekly Profit Analysis & Reliable Breakout Stock Forecasts - Newser

Dec 04, 2025
pulisher
Dec 03, 2025

Exelixis, Inc. (EXEL) Stock Forecasts - Yahoo Finance

Dec 03, 2025
pulisher
Dec 03, 2025

Exelixis to Webcast Virtual 2025 Research & Development (R&D) Day on Wednesday, December 10, 2025 - Business Wire

Dec 03, 2025
pulisher
Dec 03, 2025

Exelixis (NASDAQ:EXEL) shareholders have earned a 39% CAGR over the last three years - Yahoo Finance

Dec 03, 2025
pulisher
Dec 03, 2025

Vascular Endothelial Growth Factor Receptor (VEGFR) - openPR.com

Dec 03, 2025
pulisher
Dec 02, 2025

Is Exelixis Inc. stock a buy for dividend growthWall Street Watch & Free Community Supported Trade Ideas - Newser

Dec 02, 2025
pulisher
Dec 02, 2025

How Exelixis Inc. (EX9) stock trades under stagflationQuarterly Performance Summary & Fast Entry and Exit Trade Plans - Newser

Dec 02, 2025
pulisher
Dec 02, 2025

Will Exelixis Inc. (EX9) stock announce a stock split2025 Earnings Impact & Weekly Top Gainers Trade List - Newser

Dec 02, 2025
pulisher
Dec 02, 2025

Can Exelixis Inc. (EX9) stock retain market dominanceRate Cut & Daily Risk Controlled Trade Plans - Newser

Dec 02, 2025
pulisher
Dec 01, 2025

2 Under-the-Radar Stocks to Buy Heading Into 2026 - Finviz

Dec 01, 2025
pulisher
Dec 01, 2025

2 Under-the-Radar Stocks to Buy Heading Into 2026 - The Motley Fool

Dec 01, 2025
pulisher
Nov 29, 2025

EXEL (Exelixis) Earnings Yield (Joel Greenblatt) % : 7.99% (As of Sep. 2025) - GuruFocus

Nov 29, 2025
pulisher
Nov 29, 2025

Exelixis, Inc. (EXEL) Stock forecasts - Yahoo Finance UK

Nov 29, 2025
pulisher
Nov 29, 2025

Here's Why Exelixis (EXEL) is a Strong Growth Stock - MSN

Nov 29, 2025
pulisher
Nov 29, 2025

EXEL (Exelixis) Cash, Cash Equivalents, Marketable Securities : $989 Mil (As of Sep. 2025) - GuruFocus

Nov 29, 2025
pulisher
Nov 29, 2025

EXEL (Exelixis) Total Assets : $2,824 Mil (As of Sep. 2025) - GuruFocus

Nov 29, 2025
pulisher
Nov 28, 2025

Hedge Fund and Insider Trading News: Ray Dalio, Michael Burry, Marshall Wace, Exelixis Inc (EXEL), Monolithic Power Systems Inc (MPWR), and More - Insider Monkey

Nov 28, 2025
pulisher
Nov 28, 2025

Exelixis (LTS:0IJO) FCF Yield % : 6.28 (As of Nov. 28, 2025) - GuruFocus

Nov 28, 2025
pulisher
Nov 28, 2025

Exelixis, Inc. (EXEL) Gets Upgraded to Outperform from Market Perform by Leerink Partners - MSN

Nov 28, 2025
pulisher
Nov 27, 2025

How (EXEL) Movements Inform Risk Allocation Models - news.stocktradersdaily.com

Nov 27, 2025
pulisher
Nov 27, 2025

Exelixis Inc Stock Analysis and ForecastProtective Put Strategies & Budget Friendly Trading Strategies - earlytimes.in

Nov 27, 2025
pulisher
Nov 27, 2025

Aug Rallies: How Exelixis Inc. stock reacts to job market dataQuarterly Market Review & Free Weekly Chart Analysis and Trade Guides - moha.gov.vn

Nov 27, 2025
pulisher
Nov 27, 2025

Exelixis (EXEL) Director Invests $1.2 Million in Company Stock - GuruFocus

Nov 27, 2025
pulisher
Nov 26, 2025

Dir Johnson Buys 27,532 ($1.2M) Of Exelixis Inc [EXEL] - TradingView

Nov 26, 2025
pulisher
Nov 26, 2025

Caligan-linked Exelixis director reports 27,532-share EXEL purchase - Stock Titan

Nov 26, 2025
pulisher
Nov 26, 2025

Exelixis, Inc.Common Stock (NQ: EXEL - Markets Financial Content

Nov 26, 2025
pulisher
Nov 25, 2025

Exelixis EVP Haley sells shares worth $3m By Investing.com - Investing.com South Africa

Nov 25, 2025
pulisher
Nov 25, 2025

Exelixis Insider Sold Shares Worth $3,046,928, According to a Recent SEC Filing - marketscreener.com

Nov 25, 2025
pulisher
Nov 25, 2025

EDGAR Filing Documents for 0000939767-25-000127 - SEC.gov

Nov 25, 2025
pulisher
Nov 24, 2025

EXEL insider Form 4: EVP gifts 24,000 Exelixis shares - Stock Titan

Nov 24, 2025
pulisher
Nov 24, 2025

Exelixis EVP Haley sells shares worth $3m - Investing.com

Nov 24, 2025
pulisher
Nov 24, 2025

VP Aftab Gifts 24,000 Of Exelixis Inc [EXEL] - TradingView

Nov 24, 2025
pulisher
Nov 24, 2025

Exelixis EVP Patrick J. Haley Sells Over $3 Million in Company Stock - TradingView

Nov 24, 2025
pulisher
Nov 24, 2025

EXELIXIS INC (1EXEL.MI) Valuation Measures & Financial Statistics - Yahoo! Finance Canada

Nov 24, 2025
pulisher
Nov 24, 2025

Exelixis Is Focusing On Neuroendocrine Tumors — But Is a $100 Million Windfall Next? - Smartkarma

Nov 24, 2025
pulisher
Nov 22, 2025

Exelixis Appoints Longtime Veteran Dana T. Aftab as Head of R&D - MSN

Nov 22, 2025
pulisher
Nov 20, 2025

[Form 3] EXELIXIS, INC. Initial Statement of Beneficial Ownership - Stock Titan

Nov 20, 2025
pulisher
Nov 20, 2025

Why Exelixis Inc. stock attracts high net worth investorsQuarterly Profit Report & Fast Entry and Exit Trade Plans - newser.com

Nov 20, 2025
$39.16
price down icon 1.10%
$100.48
price down icon 1.00%
$32.03
price up icon 1.10%
$95.99
price down icon 0.77%
biotechnology ONC
$331.27
price down icon 1.95%
$205.04
price down icon 0.84%
Kapitalisierung:     |  Volumen (24h):